Entering text into the input field will update the search result below

OpGen shares gain 17% on Chinese approval of Curetis Unyvero System

  • OpGen (NASDAQ:OPGN) jumps 17% premarket after receiving regulatory approval of the Curetis Unyvero System as an in vitro diagnostics (IVD) instrument system in China.
  • A dossier for the review and potential future approval of the pneumonia cartridge was submitted in February 2019, which

Recommended For You

About OPGN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
OPGN--
OpGen, Inc.